Oramed Pharmaceuticals Inc.
ORMP | TA
Overview
Corporate Details
- ISIN(s):
- US68403P2039
- LEI:
- Country:
- Israel
- Address:
- 20 Mamilla Avenue, 9414904 Jerusalem
- Website:
- https://www.oramed.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Oramed Pharmaceuticals specializes in developing oral drug delivery systems for injectable therapies, focusing on diabetes treatment in Israel.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Oramed Pharmaceuticals Inc..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-17 15:18 |
Foreign Filer Report
FORM 10-Q- FINANCIAL STATEMENTS AS OF JUNE 30, 2025
|
English | 36.4 KB | |
| 2025-08-17 15:16 |
Major Shareholding Notification
Form 13G
|
English | 93.7 KB | |
| 2025-08-17 15:16 |
Foreign Filer Report
Form 13G
|
English | 36.4 KB | |
| 2025-07-23 17:53 |
Delisting Announcement
Option Agreement for the Repurchase of Warrants
|
English | 316.7 KB | |
| 2025-07-23 17:53 |
Foreign Filer Report
Option Agreement for the Repurchase of Warrants
|
English | 36.4 KB | |
| 2025-07-18 14:52 |
Proxy Solicitation & Information Statement
Other Report or Announcement
|
English | 1.4 MB | |
| 2025-07-18 14:52 |
Proxy Solicitation & Information Statement
Other Report or Announcement
|
English | 36.4 KB | |
| 2025-07-18 14:51 |
Registration Form
Other Report or Announcement
|
English | 448.1 KB | |
| 2025-07-18 14:51 |
Registration Form
Other Report or Announcement
|
English | 36.4 KB | |
| 2025-07-18 14:50 |
Annual / Quarterly Financial Statement
Other Report or Announcement
|
English | 359.9 KB | |
| 2025-07-18 14:50 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB | |
| 2025-06-10 11:06 |
Director's Dealing
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Reznick Yehuda
|
English | 574.4 KB | |
| 2025-06-10 11:06 |
Foreign Filer Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Reznick Yehuda
|
English | 36.2 KB | |
| 2025-05-22 08:30 |
Transaction in Own Shares
Form 8-K-a one-year extension of the Company’s current stock buyback program
|
Hebrew (modern) | 92.1 KB | |
| 2025-05-22 08:30 |
Foreign Filer Report
Form 8-K-a one-year extension of the Company’s current stock buyback program
|
Hebrew (modern) | 36.4 KB |
Automate Your Workflow. Get a real-time feed of all Oramed Pharmaceuticals Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oramed Pharmaceuticals Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nanexa AB | Sweden | NANEXA | |
|
Nanobiotix | France | NANO | |
|
Nanoform Finland OYJ | Finland | NANOFH | |
|
NanoGroup S.A. | Poland | NNG | |
|
Nattaro Labs AB | Sweden | NATTA | |
|
Neovacs | France | ALNEV | |
|
Newron Pharmaceuticals S.p.A. | Italy | NWRN | |
|
NextCell Pharma AB | Sweden | NXTCL | |
|
NextFerm Technologies Ltd. | Israel | NXFR | |
|
NFL Biosciences | France | ALNFL |